Free Trial

Nexalin Technology (NXL) Competitors

Nexalin Technology logo
$1.16 -0.03 (-2.52%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.25 +0.10 (+8.19%)
As of 07/25/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NXL vs. MDAI, CTSO, ZYXI, HYPR, SURG, ICCM, EDAP, CTCX, ECOR, and RBOT

Should you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include Spectral AI (MDAI), Cytosorbents (CTSO), Zynex (ZYXI), Hyperfine (HYPR), SurgePays (SURG), IceCure Medical (ICCM), Edap Tms (EDAP), Carmell (CTCX), electroCore (ECOR), and Vicarious Surgical (RBOT). These companies are all part of the "medical equipment" industry.

Nexalin Technology vs. Its Competitors

Nexalin Technology (NASDAQ:NXL) and Spectral AI (NASDAQ:MDAI) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Spectral AI has a net margin of -30.75% compared to Nexalin Technology's net margin of -6,529.77%. Spectral AI's return on equity of 0.00% beat Nexalin Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nexalin Technology-6,529.77% -277.92% -245.37%
Spectral AI -30.75%N/A -11.37%

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 25.3% of Nexalin Technology shares are owned by company insiders. Comparatively, 30.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Nexalin Technology has higher earnings, but lower revenue than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexalin Technology$170K117.23-$7.61M-$0.83-1.40
Spectral AI$29.58M2.23-$15.31M-$0.54-4.81

In the previous week, Nexalin Technology and Nexalin Technology both had 1 articles in the media. Nexalin Technology's average media sentiment score of 1.87 equaled Spectral AI'saverage media sentiment score.

Company Overall Sentiment
Nexalin Technology Very Positive
Spectral AI Very Positive

Nexalin Technology presently has a consensus price target of $5.00, indicating a potential upside of 331.03%. Spectral AI has a consensus price target of $4.75, indicating a potential upside of 82.69%. Given Nexalin Technology's higher possible upside, equities analysts plainly believe Nexalin Technology is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexalin Technology
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Nexalin Technology has a beta of 3.7, suggesting that its share price is 270% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500.

Summary

Spectral AI beats Nexalin Technology on 10 of the 15 factors compared between the two stocks.

Get Nexalin Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXL vs. The Competition

MetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$20.44M$2.50B$18.97B$9.50B
Dividend YieldN/A1.50%2.73%4.00%
P/E Ratio-1.4030.8429.6020.08
Price / Sales117.2339.8654.6199.95
Price / CashN/A45.9727.3958.56
Price / Book4.145.496.265.88
Net Income-$7.61M$33.53M$197.98M$258.89M
7 Day Performance6.42%2.02%1.50%3.70%
1 Month Performance16.00%9.22%5.40%11.71%
1 Year Performance-6.45%32.56%26.46%17.98%

Nexalin Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXL
Nexalin Technology
2.9937 of 5 stars
$1.16
-2.5%
$5.00
+331.0%
-0.9%$20.44M$170K-1.403Positive News
MDAI
Spectral AI
3.77 of 5 stars
$2.68
-6.3%
$4.75
+77.2%
+46.9%$67.86M$29.58M-4.9683
CTSO
Cytosorbents
1.6433 of 5 stars
$1.05
-0.9%
$5.50
+423.8%
-8.4%$65.74M$35.33M-3.75220Gap Up
ZYXI
Zynex
2.1255 of 5 stars
$2.11
-5.8%
$6.00
+184.4%
-74.7%$63.81M$192.35M-8.79770
HYPR
Hyperfine
1.4401 of 5 stars
$0.80
+4.0%
$1.06
+32.5%
-6.1%$62.27M$11.73M-1.48190News Coverage
Positive News
Gap Up
SURG
SurgePays
3.3122 of 5 stars
$2.99
-4.8%
$9.00
+201.0%
-2.0%$61.03M$40.03M-1.0740
ICCM
IceCure Medical
2.4449 of 5 stars
$1.03
-1.0%
$2.50
+142.7%
+33.8%$60.46M$3.27M-3.6860News Coverage
Gap Up
EDAP
Edap Tms
3.0597 of 5 stars
$1.51
-1.3%
$8.50
+464.8%
-70.1%$56.28M$62.77M-2.43230Positive News
CTCX
Carmell
N/A$2.68
-3.2%
N/A+306.0%$56.03M$32.84K0.0014
ECOR
electroCore
3.2681 of 5 stars
$7.45
+8.3%
$25.50
+242.3%
+29.2%$55.28M$25.18M-4.7850Positive News
RBOT
Vicarious Surgical
0.3729 of 5 stars
$9.09
+12.3%
$8.50
-6.4%
+46.6%$53.88MN/A-0.87210Gap Down

Related Companies and Tools


This page (NASDAQ:NXL) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners